Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

News

Lanarkshire business says Alfacyte could halt lung disease and prevent lasting damage in coronavirus patients   Lanarkshire-based biotech firm ILC Therapeutics has announced a research partnership with the University of St Andrews to work on a drug which could save the lives of Covid-19 patients. Scientists at ILC believe Alfacyte could be more effective...

Great news, at BioCity based Sygnature Discovery we’re further strengthening our oncology and immuno-oncology capabilities with the acquisition of Alderley Oncology, a focused in vivo pharmacology service provider which undertakes high quality in vivo services for cancer drug discovery. The acquisition will add significant in-house expertise at Sygnature in...

X
X
X
X